Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2003-2006
Title: Michaela Schneiderbauer: Innovator in Multiple Myeloma Treatment
Introduction
Michaela Schneiderbauer is a prominent inventor based in Altoetting, Germany. She has made significant contributions to the field of medical research, particularly in the treatment of multiple myeloma. With a total of 2 patents, her work focuses on innovative approaches to combat this challenging disease.
Latest Patents
Michaela's latest patents include groundbreaking methods for inhibiting the proliferation of cells associated with multiple myeloma. One of her notable inventions involves deletion mutants of the gp130 protein of the IL-3 receptor. These mutants effectively inhibit the binding of Hck tyrosine kinase, thereby reducing the growth of tumor cells, especially myeloma cells. Another significant patent describes the deletion of the Hck binding region in the IL-6 receptor, providing a novel means for treating multiple myeloma.
Career Highlights
Throughout her career, Michaela has worked with esteemed organizations such as the GSF—Forschungszentrum für Umwelt und Gesundheit GmbH. Her research has been pivotal in advancing our understanding of multiple myeloma and developing effective treatment strategies.
Collaborations
Michaela has collaborated with notable colleagues, including Michael Schaeffer and Sascha Weidler. These partnerships have enriched her research and contributed to her innovative work in the field.
Conclusion
Michaela Schneiderbauer stands out as a dedicated inventor whose work is making a difference in the fight against multiple myeloma. Her innovative patents and collaborations highlight her commitment to advancing medical research and improving patient outcomes.